N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide

C30H43N3O6S — CID 23577881

IUPACN-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide
SMILESCC(C)CNC(=O)C(C(C)C)C(O)C(O)C(Cc1ccccc1)NC(=O)c1ccc(S(=O)(=O)N2CCCC2)cc1
InChIInChI=1S/C30H43N3O6S/c1-20(2)19-31-30(37)26(21(3)4)28(35)27(34)25(18-22-10-6-5-7-11-22)32-29(36)23-12-14-24(15-13-23)40(38,39)33-16-8-9-17-33/h5-7,10-15,20-21,25-28,34-35H,8-9,16-19H2,1-4H3,(H,31,37)(H,32,36)
InChIKeyKCVWEOHZLCDHFW-UHFFFAOYSA-N
MW573.76 g/mol
LogP2.58
Rot. Bonds13

About N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide

N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide (PubChem CID 23577881) has the molecular formula C30H43N3O6S and a molecular weight of 573.76 g/mol. Its IUPAC name is N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide.

Molecular Properties

Compound NameN-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide
PubChem CID23577881
Molecular FormulaC30H43N3O6S
Molecular Weight573.76 g/mol
Exact Mass573.29
IUPAC NameN-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide
SMILESCC(C)CNC(=O)C(C(C)C)C(O)C(O)C(Cc1ccccc1)NC(=O)c1ccc(S(=O)(=O)N2CCCC2)cc1
InChIInChI=1S/C30H43N3O6S/c1-20(2)19-31-30(37)26(21(3)4)28(35)27(34)25(18-22-10-6-5-7-11-22)32-29(36)23-12-14-24(15-13-23)40(38,39)33-16-8-9-17-33/h5-7,10-15,20-21,25-28,34-35H,8-9,16-19H2,1-4H3,(H,31,37)(H,32,36)
InChIKeyKCVWEOHZLCDHFW-UHFFFAOYSA-N
XLogP2.58
TPSA136.04 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds13
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500573.76
LogP ≤ 52.58
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Analyze N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide?
The IUPAC name of N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide (CID 23577881) is N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide.
What is the SMILES notation for N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide?
The canonical SMILES for N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide is CC(C)CNC(=O)C(C(C)C)C(O)C(O)C(Cc1ccccc1)NC(=O)c1ccc(S(=O)(=O)N2CCCC2)cc1.
What is the InChIKey of N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide?
The InChIKey is KCVWEOHZLCDHFW-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H43N3O6S/c1-20(2)19-31-30(37)26(21(3)4)28(35)27(34)25(18-22-10-6-5-7-11-22)32-29(36)23-12-14-24(15-13-23)40(38,39)33-16-8-9-17-33/h5-7,10-15,20-21,25-28,34-35H,8-9,16-19H2,1-4H3,(H,31,37)(H,32,36).
What are the key properties of N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide?
N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide has a molecular weight of 573.76 g/mol, XLogP of 2.58, 13 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3,4-dihydroxy-6-methyl-5-(2-methylpropylcarbamoyl)-1-phenylheptan-2-yl]-4-pyrrolidin-1-ylsulfonylbenzamide is sourced from PubChem (CID 23577881), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).